The new year started with a bang! at Baylor College of Medicine.
Three faculty members have received major recognitions for their achievements in basic science research and technology development:
The Eberlin lab and MasSpec Pen technology: To help improve the effectiveness of surgical resection, researchers in the Eberlin Lab for Medical Mass Spectrometry at Baylor College of Medicine will receive $3 million in funding from The Marcus Foundation to further develop and validate the MasSpec Pen technology in breast cancer and other surgeries. The MasSpec Pen is a breakthrough device that was developed by Dr. Livia Eberlin and colleagues for intraoperative use and surgical guidance. Read more here.
The Deneen lab and cancer neuroscience research: The lab of Dr. Benjamin Deneen has been awarded the 2024 Edith and Peter O’Donnell Award in Medicine from the Texas Academy of Medicine, Engineering, Science & Technology (TAMEST) for opening an entirely new field of study on the mechanisms by which brain diseases develop and progress. Their findings have changed the way scientists view brain circuits, laying the groundwork for new therapeutic opportunities to combat neurological disorders. Read more here.
The Bellen lab and human genetics research: Dr. Hugo Bellen is the recipient of the 2024 Gruber Genetics Prize. This prize honors the Bellen lab’s varied and deeply impactful contributions to genetics research that range from identifying underlying mechanisms for many fundamental biological processes to how disruptions in these pathways lead to rare and common brain disorders and, finally, to finding new ways to diagnose and treat these conditions. Read more here.